Lolawest 3g L-Ornithine Oral Administration Sachets

Properties:

Hypoammoniemic agent. Reduces elevated levels of ammonia in the body, in particular in liver diseases. The action is associated with participation in the ornithine cycle of Krebs urea formation (the formation of urea from ammonia). Promotes the production of insulin and growth hormone. Improves protein metabolism in diseases requiring parenteral nutrition.

Ornithine aspartate in the body dissociates into the amino acids ornithine and aspartate, which are absorbed in the small intestine by active transport through the intestinal epithelium. Excreted with urine.

Indications:

Acute and chronic liver diseases accompanied by hyperammonemia. Hepatic encephalopathy.

For dynamic study of pituitary function.

As a corrective additive to preparations for parenteral nutrition in patients with protein deficiency.

Dosage and administration:

For oral administration – 1 sachet 1-2 times / day after meals (dissolve the contents of the sachet in half a glass of water and drink).

Duration and duration of treatment are determined individually.

Contraindications:

Severe renal dysfunction (serum creatinine more than 3 mg / 100 ml).

Precautionary measures:

When using a particular dosage form of ornithine, compliance with specific indications should be observed.

Influence on the ability to drive vehicles and control mechanisms

Ornithine can cause disturbances in concentration and speed of psychomotor reactions.